Genetic risk factors and restenosis after percutaneous coronary interventions
- PMID: 10713908
- DOI: 10.1007/BF03044122
Genetic risk factors and restenosis after percutaneous coronary interventions
Erratum in
- Herz 2000 Mar;25(2):153
Abstract
Restenosis is the major limitation of percutaneous coronary interventions. Depending on the form of intervention and patients' characteristics, 20 to 50% of the treated patients incur significant restenosis. Restenosis is caused by a complex and only partially understood cascade of events. Thrombus formation at the injury site, formation of the neointima as a result of the migration and proliferation of smooth muscle cells (SMC) and extracellular matrix production, as well as constrictive remodeling of the vessel wall contribute by a variable degree to restenosis. Restenosis is not a random event but it affects selectively a certain subset of patients. These patients have some peculiar characteristics that help to identify the presence of a higher risk for restenosis. Conventional patient-related factors account only for a relatively small portion of the predictive power, much more contribution comes from lesion and procedural characteristics. There is increasing evidence that inherited factors may explain at least part of the excessive risk for restenosis observed in certain patients. Evidence exists that gene polymorphisms may lead to quantitative or functional alterations of the respective gene products. Recent studies have also found significant associations between several polymorphic alleles encoding for proteins with a relevant role in the process of lumen renarrowing and restenosis after percutaneous coronary interventions. The best studied polymorphisms in this regard are those of the genes encoding for angiotensin-converting enzyme and platelet glycoprotein-IIIa. Completed or ongoing studies have focused on polymorphisms of genes encoding for proteins interfering with lipid metabolism, hemostasis, nitric oxide production, inflammatory mechanisms, SMC proliferation and matrix production. The results of this research will have considerable pathophysiological and therapeutical implications for the battle against restenosis.
Similar articles
-
Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.Eur Heart J. 1995 Oct;16(10):1331-46. doi: 10.1093/oxfordjournals.eurheartj.a060740. Eur Heart J. 1995. PMID: 8746901
-
Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.J Am Coll Cardiol. 2001 Nov 1;38(5):1434-9. doi: 10.1016/s0735-1097(01)01580-7. J Am Coll Cardiol. 2001. PMID: 11691520
-
Polymorphism of platelet glycoprotein IIb and risk of thrombosis and restenosis after coronary stent placement.Am J Cardiol. 1999 Nov 1;84(9):987-91. doi: 10.1016/s0002-9149(99)00485-3. Am J Cardiol. 1999. PMID: 10569651
-
Gene therapy for restenosis after balloon angioplasty and stenting.Cardiol Rev. 1999 Nov-Dec;7(6):324-31. doi: 10.1097/00045415-199911000-00010. Cardiol Rev. 1999. PMID: 11208244 Review.
-
Ischemia: reperfusion injury and restenosis after coronary angioplasty.Ann N Y Acad Sci. 1992 Sep 30;669:215-36. doi: 10.1111/j.1749-6632.1992.tb17102.x. Ann N Y Acad Sci. 1992. PMID: 1444028 Review.
Cited by
-
New developments in endovascular interventions for extracranial carotid stenosis.Tex Heart Inst J. 2000;27(3):273-80. Tex Heart Inst J. 2000. PMID: 11093412 Free PMC article. Review.
-
Genetic risk factors for restenosis after percutaneous coronary intervention in Kazakh population.Hum Genomics. 2016 Jun 8;10(1):15. doi: 10.1186/s40246-016-0077-z. Hum Genomics. 2016. PMID: 27277665 Free PMC article.
-
A comparative study of restenosis rates in bare metal and drug-eluting stents.Int J Angiol. 2010 Summer;19(2):e66-72. doi: 10.1055/s-0031-1278368. Int J Angiol. 2010. PMID: 22477592 Free PMC article.
-
Restenosis after percutaneous angioplasty: the role of vascular inflammation.Vasc Health Risk Manag. 2005;1(1):73-8. doi: 10.2147/vhrm.1.1.73.58932. Vasc Health Risk Manag. 2005. PMID: 17319099 Free PMC article. Review.
-
Long-term outcome after coronary stenting.Curr Control Trials Cardiovasc Med. 2000;1(1):48-54. doi: 10.1186/cvm-1-1-048. Curr Control Trials Cardiovasc Med. 2000. PMID: 11714409 Free PMC article.